Sepsis induces early alterations in innate immunity that impact mortality to secondary infection
- PMID: 21106855
- PMCID: PMC3771366
- DOI: 10.4049/jimmunol.1002104
Sepsis induces early alterations in innate immunity that impact mortality to secondary infection
Abstract
Sepsis, the systemic inflammatory response to microbial infection, induces changes in both innate and adaptive immunity that presumably lead to increased susceptibility to secondary infections, multiorgan failure, and death. Using a model of murine polymicrobial sepsis whose severity approximates human sepsis, we examined outcomes and defined requirements for survival after secondary Pseudomonas aeruginosa pneumonia or disseminated Listeria monocytogenes infection. We demonstrate that early after sepsis neutrophil numbers and function are decreased, whereas monocyte recruitment through the CCR2/MCP-1 pathway and function are enhanced. Consequently, lethality to Pseudomonas pneumonia is increased early but not late after induction of sepsis. In contrast, lethality to listeriosis, whose eradication is dependent upon monocyte/macrophage phagocytosis, is actually decreased both early and late after sepsis. Adaptive immunity plays little role in these secondary infectious responses. This study demonstrates that sepsis promotes selective early, impaired innate immune responses, primarily in neutrophils, that lead to a pathogen-specific, increased susceptibility to secondary infections.
Figures







References
-
- Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001;29:1303–1310. - PubMed
-
- Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554. - PubMed
-
- Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503. - PubMed
-
- Cross AS, Opal SM. A new paradigm for the treatment of sepsis: is it time to consider combination therapy? Ann Intern Med. 2003;138:502–505. - PubMed
Publication types
MeSH terms
Grants and funding
- R37 GM040586/GM/NIGMS NIH HHS/United States
- R01 DK074656/DK/NIDDK NIH HHS/United States
- T32 AR007603/AR/NIAMS NIH HHS/United States
- DE-016509/DE/NIDCR NIH HHS/United States
- U24 DE016509/DE/NIDCR NIH HHS/United States
- R01 GM081923/GM/NIGMS NIH HHS/United States
- R01 GM-81923/GM/NIGMS NIH HHS/United States
- R01 GM040586/GM/NIGMS NIH HHS/United States
- R01 GM-40586/GM/NIGMS NIH HHS/United States
- T32 GM-08431/GM/NIGMS NIH HHS/United States
- T32 GM008721/GM/NIGMS NIH HHS/United States
- T32 CA-106493/CA/NCI NIH HHS/United States
- T32 AR-007603/AR/NIAMS NIH HHS/United States
- T32 CA106493/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous